Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment

@article{buckley2026prognostic,
  title = {{Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment}},
  author = {Rachel F. Buckley and Diana L Townsend and Colin Birkenbihl and Madison Cuppels and Gillian Coughlan and Mabel T. Seto and Jane A. Brown and Michael J Properzi and Merle C. Hönig and Annie Li and Aaron P. Schultz and Jasmeer P. Chhatwal and Hyun-Sik Yang and Steven Edward Arnold and Pia Kivisäkk and Bryan David James and Sid E. O’Bryant and Robert A. Rissman and Melissa E. Petersen and Jessica K. Caldwell and Tobey J. Betthauser and Julie Elisabeth Oomens and Maria Carrigan and Brian C. Healy and Jorge García Condado and Sterling C. Johnson and Wai‐Ying Wendy Yau and Oliver Langford and Michelle E. Farrell and Rebecca England Amariglio and Dorene M. Rentz and Kathryn V. Papp and Ron Brookmeyer and Timothy J. Hohman and Michael Donohue and Paul S. S Aisen and Keith A. Johnson and Reisa Anne Sperling and Alzheimer’s Disease Neuroimaging Initiative, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies, Harvard Aging Brain Study (HABS), Health \& Aging Brain Study – Health D and Reisa Anne Sperling and Paul S. S Aisen and Roy Yaari and Cheryl A. Brown and John Randall Sims and Keith A. Johnson and Clifford R. Jack and James B. Brewer and Jason H. Karlawish and Joshua D. Grill and Marybeth Howlett and Paul T. Maruff and Kenneth Marek and John Peter Seibyl and Mark Mintun and Karen Chilcott Holdridge and Isabella Velonà and Alison Belsha and Jeremy Pizzola and Robert A. Rissman and Cecily Jenkins},
  journal = {JAMA},
  year = {2026},
  month = jul,
  doi = {10.1001/jama.2026.12556},
  url = {https://discovery.ucl.ac.uk/id/eprint/10232409/},
}

TY  - JOUR
TI  - Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment
AU  - Rachel F. Buckley
AU  - Diana L Townsend
AU  - Colin Birkenbihl
AU  - Madison Cuppels
AU  - Gillian Coughlan
AU  - Mabel T. Seto
AU  - Jane A. Brown
AU  - Michael J Properzi
AU  - Merle C. Hönig
AU  - Annie Li
AU  - Aaron P. Schultz
AU  - Jasmeer P. Chhatwal
AU  - Hyun-Sik Yang
AU  - Steven Edward Arnold
AU  - Pia Kivisäkk
AU  - Bryan David James
AU  - Sid E. O’Bryant
AU  - Robert A. Rissman
AU  - Melissa E. Petersen
AU  - Jessica K. Caldwell
AU  - Tobey J. Betthauser
AU  - Julie Elisabeth Oomens
AU  - Maria Carrigan
AU  - Brian C. Healy
AU  - Jorge García Condado
AU  - Sterling C. Johnson
AU  - Wai‐Ying Wendy Yau
AU  - Oliver Langford
AU  - Michelle E. Farrell
AU  - Rebecca England Amariglio
AU  - Dorene M. Rentz
AU  - Kathryn V. Papp
AU  - Ron Brookmeyer
AU  - Timothy J. Hohman
AU  - Michael Donohue
AU  - Paul S. S Aisen
AU  - Keith A. Johnson
AU  - Reisa Anne Sperling
AU  - Alzheimer’s Disease Neuroimaging Initiative, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies, Harvard Aging Brain Study (HABS), Health & Aging Brain Study – Health D
AU  - Reisa Anne Sperling
AU  - Paul S. S Aisen
AU  - Roy Yaari
AU  - Cheryl A. Brown
AU  - John Randall Sims
AU  - Keith A. Johnson
AU  - Clifford R. Jack
AU  - James B. Brewer
AU  - Jason H. Karlawish
AU  - Joshua D. Grill
AU  - Marybeth Howlett
AU  - Paul T. Maruff
AU  - Kenneth Marek
AU  - John Peter Seibyl
AU  - Mark Mintun
AU  - Karen Chilcott Holdridge
AU  - Isabella Velonà
AU  - Alison Belsha
AU  - Jeremy Pizzola
AU  - Robert A. Rissman
AU  - Cecily Jenkins
PY  - 2026
DA  - 2026/07/15
JO  - JAMA
DO  - 10.1001/jama.2026.12556
UR  - https://discovery.ucl.ac.uk/id/eprint/10232409/
SN  - 0002-9955
SN  - 0098-7484
SN  - 1538-3598
SN  - 2376-8118
ER  -